Light grey background with rounded corners

Understanding Peptide Binding to MHC Class I and II Molecules

T Cell Recognition and Co-Receptor Function

Adaptive immunity depends on the specific recognition of an antigenic peptide bound to a major histocompatibility complex (pMHC) molecule by a T cell receptor (TCR) on the surface of T cells. However, TCR–pMHC interactions alone are not sufficient to fully activate T cells — they require the participation of the co-receptors CD4 and CD8.

These transmembrane glycoproteins define distinct T cell subsets:

CD4 is expressed on helper T cells (Th1, Th2, Th17) and regulatory T cells (Tregs).
CD8 is found on cytotoxic T lymphocytes (CTLs) and CD8 regulatory T cells.

CD4 and CD8 enhance T cell signaling by binding specifically to MHC class II and MHC class I molecules, respectively, on antigen-presenting cells (APCs) — ensuring precise and efficient communication within the adaptive immune system.

Antigen Processing and Presentation Pathways

MHC molecules serve as transport systems that link intracellular or extracellular antigen sources to the cell surface, where T cells can recognize them.

MHC Class I

acts as a transporter between the cytoplasmic compartment and the cell surface. It primarily presents endogenous antigens — proteins that are newly synthesized within the cell, including self-antigens, viral peptides, and tumor-associated antigens.

These proteins are partially degraded in the cytoplasm by the proteasome, transported into the endoplasmic reticulum via TAP (Transporter associated with Antigen Processing), and loaded onto MHC class I molecules before being displayed on the cell surface.

Thus, CD8⁺ T cells mainly recognize endogenously derived peptides, allowing them to monitor the intracellular health of the organism and eliminate infected or transformed cells.

Drawing of a cell with endogenous tumor or viral antigens, its MHC class I molecule and a recognising T cell receptor

MHC Class II

by contrast, functions as a transport system between endosomes and the cell surface. It presents exogenous antigens — proteins that originate from outside the cell.

These foreign particles, such as bacterial, fungal, or parasitic proteins, as well as soluble antigens, are internalized via endocytosis and degraded into peptides within the endosomal compartment.

The MHC class II molecule then binds these peptides and transports them to the cell surface, where they are presented to CD4⁺ T helper cells, which orchestrate immune responses through cytokine release and B cell activation.

Drawing of a cell taking up exogenous bacterial, fungal or parasitic antigens, its MHC class II molecule and a recognising T cell receptor

MHC Class I

acts as a transporter between the cytoplasmic compartment and the cell surface. It primarily presents endogenous antigens — proteins that are newly synthesized within the cell, including self-antigens, viral peptides, and tumor-associated antigens.

These proteins are partially degraded in the cytoplasm by the proteasome, transported into the endoplasmic reticulum via TAP (Transporter associated with Antigen Processing), and loaded onto MHC class I molecules before being displayed on the cell surface.

Thus, CD8⁺ T cells mainly recognize endogenously derived peptides, allowing them to monitor the intracellular health of the organism and eliminate infected or transformed cells.

Drawing of a cell with endogenous tumor or viral antigens, its MHC class I molecule and a recognising T cell receptor

MHC Class II

by contrast, functions as a transport system between endosomes and the cell surface. It presents exogenous antigens — proteins that originate from outside the cell.

These foreign particles, such as bacterial, fungal, or parasitic proteins, as well as soluble antigens, are internalized via endocytosis and degraded into peptides within the endosomal compartment.

The MHC class II molecule then binds these peptides and transports them to the cell surface, where they are presented to CD4⁺ T helper cells, which orchestrate immune responses through cytokine release and B cell activation.

Drawing of a cell taking up exogenous bacterial, fungal or parasitic antigens, its MHC class II molecule and a recognising T cell receptor

Structural Differences Between MHC Class I and II Binding Grooves

MHC Class I: A Closed Groove with Defined Peptide Length

The MHC class I binding groove is closed at both ends, which restricts the length of peptides it can accommodate. Typically, MHCI binds short peptides of 8–10 amino acids, most often nonamers.

Peptides bind in an extended conformation, depending on anchor residues—specific amino acids that fit into deep hydrophobic pockets, most commonly at positions P2 and P9.

These anchor interactions stabilize the peptide–MHC complex, while exposed residues project upward to interact with the T cell receptor (TCR) and determine antigen specificity.

Drawing of the MHC class I binding groove binding a nonamer peptide

MHC Class II: An Open Groove with Extended Peptide Binding

In contrast, the MHC class II binding groove is open at both ends, allowing peptides of variable lengths (typically 13–25 amino acids) to bind. The peptides can extend beyond the groove, resulting in more flexible and diverse antigen presentation to CD4⁺ T cells.

The bound peptide typically adopts a type II polyproline helix [3, 4 in Ferrante, 2007] conformation that fits into specific binding pockets within the MHC class II molecule. Major anchor positions are located at P1, P4, P6, and P9, where the side chains of certain amino acids interact with deep, hydrophobic or charged pockets in the MHC molecule:

P1: often accommodates an aromatic amino acid (e.g., phenylalanine, tyrosine, or tryptophan)
P4: typically binds a hydrophobic or polar/charged amino acid
P6: recognizes an amino acid specific to the individual MHC II allele
P9: prefers a hydrophobic amino acid

Minor anchor residues at positions such as P2, P3, P7, and P10 can further stabilize the interaction.

Drawing of the MHC class II binding groove binding a 13-mer peptide

Drawing of the MHC class II binding groove binding a 13-mer peptide

MHC Class I: A Closed Groove with Defined Peptide Length

The MHC class I binding groove is closed at both ends, which restricts the length of peptides it can accommodate. Typically, MHCI binds short peptides of 8–10 amino acids, most often nonamers.

Peptides bind in an extended conformation, depending on anchor residues—specific amino acids that fit into deep hydrophobic pockets, most commonly at positions P2 and P9.

These anchor interactions stabilize the peptide–MHC complex, while exposed residues project upward to interact with the T cell receptor (TCR) and determine antigen specificity.

Drawing of the MHC class I binding groove binding a nonamer peptide

MHC Class II: An Open Groove with Extended Peptide Binding

In contrast, the MHC class II binding groove is open at both ends, allowing peptides of variable lengths (typically 13–25 amino acids) to bind. The peptides can extend beyond the groove, resulting in more flexible and diverse antigen presentation to CD4⁺ T cells.

The bound peptide typically adopts a type II polyproline helix [3, 4 in Ferrante, 2007] conformation that fits into specific binding pockets within the MHC class II molecule. Major anchor positions are located at P1, P4, P6, and P9, where the side chains of certain amino acids interact with deep, hydrophobic or charged pockets in the MHC molecule:

P1: often accommodates an aromatic amino acid (e.g., phenylalanine, tyrosine, or tryptophan)
P4: typically binds a hydrophobic or polar/charged amino acid
P6: recognizes an amino acid specific to the individual MHC II allele
P9: prefers a hydrophobic amino acid

Minor anchor residues at positions such as P2, P3, P7, and P10 can further stabilize the interaction.

Drawing of the MHC class II binding groove binding a 13-mer peptide

Explore peptides&elephants' 👉 Peptide Pools — ready-to-use peptide mixes for the stimulation of antigen-specific CD8⁺ and CD4+ T cells.

Summary: Matching Peptides to MHC Class I and II

Feature	MHC Class I	MHC Class II
Peptide source	Endogenous (self, viral, tumor)	Exogenous (bacterial, fungal, parasitic, soluble proteins)
Peptide length	8–10 amino acids	13–25 amino acids
Groove structure	Closed at both ends	Open at both ends
Anchor positions	P2, P9	P1, P4, P6, P9 (+ minor anchors)
Recognized by	CD8⁺ cytotoxic T cells	CD4⁺ helper T cells

Understanding these differences is critical for designing peptide-based vaccines, T cell assays, and epitope mapping strategies that align with either class I or class II presentation pathways.

Feature	MHC Class I	MHC Class II
Peptide source	Endogenous (self, viral, tumor)	Exogenous (bacterial, fungal, parasitic, soluble proteins)
Peptide length	8–10 amino acids	13–25 amino acids
Groove structure	Closed at both ends	Open at both ends
Anchor positions	P2, P9	P1, P4, P6, P9 (+ minor anchors)
Recognized by	CD8⁺ cytotoxic T cells	CD4⁺ helper T cells

Understanding these differences is critical for designing peptide-based vaccines, T cell assays, and epitope mapping strategies that align with either class I or class II presentation pathways.

Designing Peptides for Optimal MHC Binding

Understanding the structural preferences of the MHCI and MHCII binding grooves is key when designing epitope-specific peptide pools.

Through custom peptide synthesis, researchers can introduce post-translational modifications, variant peptides, or computationally predicted epitopes to fine-tune antigen presentation and T cell activation.

These capabilities make peptides&elephants peptide pools powerful, flexible tools for advancing cancer immunology, infectious disease research, and vaccine development.

drawing of the core element of the USPS platform controlled by a scientist